For breast cancer, most of the studies including BRCA1 mutation carriers with and without RRBSO did not find an increase in risk associated with HRT, neither for woman after surgical, nor after natural menopause (Kotsopoulos et al. 2016; Eisen et al. 2008). The gene discussed is BRCA1; the disease is breast carcinoma.